From: University Relations

The New River Health District began providing COVID-19 vaccinations to those in Phase 2 on Friday, which includes all college students.

Phase 2 means that everyone ages 16 and older who lives or works in the district will be eligible to get the vaccine. During the transition period, the district is initially targeting college students, then will open fully to Phase 2.

“We continue to vaccinate people in Phases 1a and 1b,” said Noelle Bissell, director of the health district, in a news release. “We have reached out to all who were registered and to major employee groups in those phases. We are at the point where we have openings in the schedule and can move to the next phase.”

Appointments are required to receive a vaccine. The health district uses the Everbridge automated scheduling system and the Vaccine Scheduling Center at 540-838-8222 to make vaccine appointments. Online links will be added to the website as soon as possible to allow individuals to schedule appointments.

To get the COVID-19 vaccine, you must first pre-register. Visit the vaccine pre-registration page for information on how to sign up for the vaccine. If you have already pre-registered, go to and verify you are in the system and your information is complete.

Those in isolation or quarantine for COVID-19 or who have another illness with a fever are not eligible for a vaccine until these conditions are resolved. Those who have had COVID-19 and received monoclonal antibodies or plasma treatment are not eligible to receive a vaccine until 90 days after treatment. Those who have had a vaccine within the last 14 days should wait to schedule their COVID-19 vaccine until 14 days have elapsed since their other vaccination.

All New River Valley residents are encouraged to see the latest vaccine information at For general COVID-19 questions, call 540-267-8240.

The Virginia Department of Health continues to lead vaccine distribution for the commonwealth, and Virginia Tech continues to support the department's efforts.


Share this story